Replies to post #2112 on GTC Biotherapeutics (fka GTCB)

[dewophile]

re control arm

from your post I gather controls will be eligible for treatment with plasma-derived ATIII where available..almost seems like a non-inferiority would be most appropriate if an inordinately high proportion of docs, based on kybersept, already tend to treat with ATIII/no heparin, no?